Literature DB >> 3099946

Effectiveness of intravenous acyclovir in immunocompetent patient with herpes zoster encephalitis.

M K Whyte, P W Ind.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3099946      PMCID: PMC1342310          DOI: 10.1136/bmj.293.6561.1536

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  5 in total

1.  A case of herpes zoster associated encephalitis with rapid response to acyclovir.

Authors:  J S Cheesbrough; R G Finch; M J Ward
Journal:  Postgrad Med J       Date:  1985-02       Impact factor: 2.401

2.  Treatment of varicella-zoster meningoencephalitis with acyclovir--demonstration of virus in cerebrospinal fluid by electron microscopy.

Authors:  R W Steele; R E Keeney; R W Bradsher; E B Moses; B L Soloff
Journal:  Am J Clin Pathol       Date:  1983-07       Impact factor: 2.493

3.  Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients.

Authors:  B Sköldenberg; M Forsgren; K Alestig; T Bergström; L Burman; E Dahlqvist; A Forkman; A Frydén; K Lövgren; K Norlin
Journal:  Lancet       Date:  1984-09-29       Impact factor: 79.321

4.  A new marker for human cancer cells. 1 The Ca antigen and the Ca1 antibody.

Authors:  F Ashall; M E Bramwell; H Harris
Journal:  Lancet       Date:  1982-07-03       Impact factor: 79.321

5.  Acyclovir halts progression of herpes zoster in immunocompromised patients.

Authors:  H H Balfour; B Bean; O L Laskin; R F Ambinder; J D Meyers; J C Wade; J A Zaia; D Aeppli; L E Kirk; A C Segreti; R E Keeney
Journal:  N Engl J Med       Date:  1983-06-16       Impact factor: 91.245

  5 in total
  3 in total

Review 1.  Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  J J O'Brien; D M Campoli-Richards
Journal:  Drugs       Date:  1989-03       Impact factor: 9.546

Review 2.  Cognitive outcome in acute sporadic encephalitis.

Authors:  L Hokkanen; J Launes
Journal:  Neuropsychol Rev       Date:  2000-09       Impact factor: 6.940

3.  Subcortical type cognitive impairment in herpes zoster encephalitis.

Authors:  L Hokkanen; J Launes; E Poutiainen; L Valanne; O Salonen; J Sirén; M Iivanainen
Journal:  J Neurol       Date:  1997-04       Impact factor: 6.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.